Josh Bilenker
Aisling Capital Partner
investment range
sweet spot
Josh Bilenker's Past Investments (15)
| Company | Deal Type | Amount | Date | |
|---|---|---|---|---|
| ViewRay | Post-IPO Equity | $26.7M | Jul 2015 | |
| LensAR | Private Equity Round | $16M | Jan 2015 | |
| Loxo Oncology | Series B | $24M | May 2014 | |
| ViewRay | Venture Round | $30M | Dec 2013 | |
| LensAR | Debt Financing | $60M | Oct 2013 | |
| LensAR | Private Equity Round | $27M | Oct 2013 | |
| ViewRay | Venture Round | $15M | May 2013 | |
| T2 Biosystems | Series E | $40M | Mar 2013 | |
| Aragon Pharmaceuticals | Series D | $50M | Oct 2012 | |
| ViewRay | Series C | $45M | Mar 2012 |
Josh Bilenker's Media
No media found for Josh Bilenker.